Vitamin C: High-Dose Supplementation — What It Does and Doesn't Do

Vitamin C prevents scurvy and supports collagen synthesis, but megadose claims (immune boosting, cancer treatment, cold prevention) have a mixed evidence profile. This guide explains what the research shows.

3 min read · 557 wordsReviewed May 2026
High-angle shot of a white bottle filled with round tablets on a textured background. - Evidence evidence guide for Vitamin C: High-Dose Supplementation — What It Does and Doesn't Do
Photo by Supplements On Demand on Pexels · Pexels License

Quick Answer

Vitamin C is essential for collagen synthesis, immune function, and antioxidant defence. Most adults get adequate amounts from diet.

Key Takeaways

  • 01---
  • 02| Dose | % Absorbed | Plasma Level |
  • 03|---|---|---|
  • 04| 200 mg | ~100% | ~12–15 µmol/L |
  • 05| 500 mg | ~73% | Marginally higher |

Quick Answer

Vitamin C is essential for collagen synthesis, immune function, and antioxidant defence. Most adults get adequate amounts from diet. High-dose supplementation (>1 g/day) reduces cold duration by about 8% in general populations — a modest effect. Megadose claims for cancer, immune "boosting," or as an antiviral are not adequately supported by clinical trial data.


Dietary vs Supplemental Needs

The body saturates vitamin C absorption at approximately 200 mg/day from food. Above this, absorption efficiency drops sharply — only about 50% of a 500 mg dose and roughly 12% of a 1,250 mg dose is absorbed. Excess is excreted rapidly in urine.

Dose % Absorbed Plasma Level
200 mg ~100% ~12–15 µmol/L
500 mg ~73% Marginally higher
1,250 mg ~46% Near ceiling
12,000 mg ~16% Ceiling reached

For most people, 200 mg from a varied diet achieves near-maximal plasma levels. Supplementing beyond this primarily affects urine vitamin C levels.


The Common Cold: What the Data Shows

A 2013 Cochrane review (21 trials, n=10,000+) is the definitive reference:

  • Prevention in general population: Regular supplementation does not reduce cold incidence.
  • Reduction in duration: Regular supplementation reduces cold duration by ~8% in adults (about half a day) and ~14% in children.
  • Prevention in extreme conditions: Athletes, soldiers, and people under extreme physical stress may see reduced incidence with supplementation.
  • Therapeutic use (taking at onset): Only one large trial exists; limited effect.

Antioxidant Effect vs Pro-Oxidant Risk

At physiological concentrations, vitamin C is a primary antioxidant. At very high plasma concentrations (achievable only via IV, not oral), it can act as a pro-oxidant in some contexts. This duality is why high-dose IV vitamin C research in cancer is complicated to interpret.


Vitamin C and Collagen Synthesis

Vitamin C is directly required as a cofactor for prolyl and lysyl hydroxylases, the enzymes that crosslink collagen. This is not a supplementation benefit claim — it reflects the essential role vitamin C plays in the mechanism. Adequate vitamin C is necessary; excess does not produce extra collagen.


Dosage Reference

Context Recommended Dose
RDA (adults) 75–90 mg/day (women/men)
Smokers (increased oxidative stress) +35 mg/day above RDA
General supplementation 200–500 mg/day
Upper tolerable limit 2,000 mg/day
Cold treatment 1,000 mg/day while symptomatic (modest evidence)

Safety Notes

  • Kidney stones: Vitamin C is metabolised partly to oxalate. People with a history of oxalate kidney stones should limit supplemental vitamin C to 500 mg/day.
  • Haemochromatosis: Vitamin C enhances iron absorption; avoid high doses in haemochromatosis.
  • GI upset (diarrhoea) is the primary dose-limiting side effect and typically resolves at doses below 2 g/day.
  • Drug interactions: May affect warfarin levels at very high doses; monitor INR.

Practical Next Steps

  1. Adequate diet (5 servings of fruit and vegetables) typically provides 150–200 mg/day.
  2. If supplementing, 200–500 mg/day is a reasonable pragmatic dose.
  3. During colds, 1 g/day reduces duration modestly; evidence does not support benefit from higher doses.
  4. Megadose protocols (>10 g/day) have minimal evidence for any indication outside clinical IV use in specific contexts.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed May 9, 2026 by Migaku Editorial Team

Related content

← All GuidesSupplement Reference →